Timepoint at which developing B-cells become cancerous impacts leukemia treatment

Scientists at St. Jude  Children’s Research Hospital and University Health Network showed that the stage of B-cell development at which leukemia arises impacts B-ALL therapy response and clinical outcome.

Read more: https://www.stjude.org/media-resources/news-releases/2025-medicine-science-news/timepoint-at-which-developing-b-cells-become-cancerous-impacts-leukemia-treatment.html